Asian Journal of Research in Botany

Turmeric (Curcuma longa), a perennial herb of the Zingiberaceae family, has held a prominent place in traditional medicine systems such as Ayurveda, Unani, and Traditional Chinese Medicine for centuries. Its principal bioactive constituent, curcumin, along with other curcuminoids and essential oils, contributes to a broad spectrum of pharmacological effects, including anti-inflammatory, antioxidant, antimicrobial, anticancer, neuroprotective, antidiabetic, analgesic, hepatoprotective, and immunomodulatory activities. Medicinally, turmeric has been used for the treatment of wounds, skin disorders, respiratory ailments, digestive complaints, and liver diseases. Despite its promising bioactivities, curcumin’s poor aqueous solubility, rapid metabolism, and limited systemic bioavailability have posed significant challenges for its clinical application. In response, advanced drug delivery systems—including nanoparticles, liposomes, Niosomes, phytosomes, and curcumin analogs—have been developed to enhance its bioefficacy, stability, and therapeutic potential. The integration of turmeric-derived compounds into functional foods, dietary supplements, and topical formulations has further expanded its role in both preventive and therapeutic healthcare. This review explores turmeric’s transformation from an ethnomedicinal remedy to a modern phytopharmaceutical agent, highlighting recent advancements in formulation technologies, outcomes of contemporary clinical trials, and regulatory considerations. By bridging traditional knowledge with modern science, turmeric continues to emerge as a promising, safe, and affordable candidate in the development of next-generation therapeutic agents.